Keyphrases
Glucagon
100%
Glucagon-like
47%
Type 2 Diabetes Mellitus (T2DM)
36%
Roux-en-Y Gastric Bypass
30%
Glucagon Receptor
24%
Bariatric Surgery
21%
Obesity
21%
Non-alcoholic Fatty Liver Disease (NAFLD)
20%
Glucagon Secretion
17%
Amino Acids
17%
Insulin
14%
Hyperglucagonemia
12%
Liver Cells
12%
Plasma Concentration
12%
Liver
12%
Hepatic Steatosis
11%
Metabolic-associated Fatty Liver Disease (MAFLD)
11%
Sacubitril-valsartan
10%
Alpha Cell
10%
Glucagon-like peptide-1 (GLP-1)
10%
Receptor Signaling
9%
Amino Acid Metabolism
9%
A1 Receptor
9%
Weight Loss
9%
Obese Men
9%
Interleukin-6
9%
Healthy Individuals
8%
Ureagenesis
8%
Sleeve Gastrectomy
8%
Bile Acids
8%
Randomized Placebo-controlled Trial
7%
Gastric Emptying
7%
Oxyntomodulin
7%
Gastric Sleeve
7%
Blood Glucose
7%
Glycemic Control
6%
Cirrhosis
6%
Small Intestine
6%
Neprilysin
6%
Glucose-dependent Insulinotropic Polypeptide
6%
Placebo
6%
Body Mass Index
6%
Diabetes
6%
Nonalcoholic Steatohepatitis
6%
Receptor Agonist
6%
Lipid Metabolism
6%
Meal Tolerance Test
6%
Agonism
6%
Angiotensin Receptor-neprilysin Inhibitor
6%
Peptide YY
6%
Medicine and Dentistry
Glucagon
47%
Glucagon Like Peptide 1
30%
Roux-en-Y Gastric Bypass
29%
Maturity Onset Diabetes of the Young
22%
Secretion (Process)
22%
Bariatric Surgery
21%
Nonalcoholic Fatty Liver
16%
Meal
14%
Amino Acid
12%
Sleeve Gastrectomy
10%
Oxyntomodulin
10%
Placebo
10%
Fatty Liver
9%
Diabetes
9%
Body Mass Index
8%
Proteomics
8%
Liver Cirrhosis
7%
Disease
7%
Gastric Bypass Surgery
7%
Glucagon Receptor
7%
Placebo-Controlled Study
7%
Bile Acid
7%
Gastrointestinal Hormone
7%
Glucagon Release
7%
Body Weight
7%
Gluconeogenesis
7%
Impaired Glucose Tolerance
7%
Insulin Sensitivity
6%
Incretin
6%
Liver Disease
6%
Glucagon-Like Peptide-1 Agonist
6%
Glycemic Control
6%
Infusion
6%
Gut
5%
Hyperglucagonemia
5%
Metabolomics
5%
Stomach Emptying
5%
Gastric Inhibitory Polypeptide
5%
Gastric Bypass
5%
Small Intestine
5%
Interleukin 6
5%
Chenodeoxycholic Acid
5%
Randomized Clinical Trial
5%
Fat Intake
5%
Liver Cell
5%
Glycon
5%
Biochemistry, Genetics and Molecular Biology
Glucagon
81%
Mouse
31%
Secretion (Process)
30%
Glucagon-Like Peptide-1
29%
Amino Acids
26%
Glucagon Receptor
25%
Glucagon Release
17%
Glucose Blood Level
15%
Proteomics
13%
Glucagon Blood Level
10%
Metabolic Pathway
10%
Proteome
10%
Gluconeogenesis
9%
Blood Level
9%
Amino Acid Metabolism
8%
Urea Cycle
8%
Interleukin 6
7%
Glucagon-Like Peptide 1 Receptor
7%
Enteroglucagon
7%
Lipid Metabolism
7%
Insulin Resistance
6%
Incretin
6%
Impaired Glucose Tolerance
6%
Receptor Antagonist
6%
Alanine
6%
Insulin Receptor
6%
Stomach Emptying
5%
Insulin Release
5%
Mass Spectrometry
5%
Small Intestine
5%
Gastric Inhibitory Polypeptide
5%
Arginine
5%
Bile Acid
5%
Triglyceride
5%
Peptide YY
5%
Glucagon
5%